Use of MRI in the Assessment of Patients with Stroke
- 401 Downloads
Multimodal neuroimaging is assuming an increasingly important role in the initial evaluation and management of acute stroke patients in parallel with the expansion of therapeutic options. Multimodal MRI can identify the type of stroke (ischemia or hemorrhage), severity and location of the lesion, the patency of the intracranial vessels, the degree of cerebral perfusion, and the presence and size of the ischemic penumbra. This information can be used to guide both acute and long-term treatment decisions for stroke patients.
KeywordsStroke MRI DWI PWI MRA Ischemia Hemorrhage Penumbra
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
- 3.•• Chalela JA, Kidwell CS, Nentwich LM, et al.: Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet 2007, 369:293–298. This article demonstrate the utility of DWI compared with CT for detecting stroke.CrossRefPubMedGoogle Scholar
- 6.•• Easton JD, Saver JL, Albers GW, et al.: Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy Of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke 2009, 40:2276–2293. This article revised the approach to defining TIA and stroke using a tissue-based rather than time-based definition.CrossRefPubMedGoogle Scholar
- 17.The Internet Stroke Center: Stroke Trials Registry—MR Rescue: Magnetic Resonance and Recanalization of Stroke Clots Using Embolectomy. Available at http://www.strokecenter.org/trials/TrialDetail.aspx?tid=559. Accessed September 2010.
- 23.•• Davis SM, Donnan GA, Parsons MW, et al.: Effects of alteplase beyond 3 h after stroke in the echoplanar imaging thrombolytic evaluation trial (epithet): a placebo-controlled randomised trial. Lancet Neurol 2008, 7:299–309. This is the first randomized trial using MRI screening to select patients for treatment with IV tPA up to 6 hours.CrossRefPubMedGoogle Scholar
- 41.U.S. Food and Drug Administration: Information for Healthcare Professionals Gadolinium-Based Contrast Agents for Magnetic Resonance Imaging (marketed as Magnevist, Multihance, Omniscan, Optimark, Prohance). Available at http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm142884.htm. Accessed September 2010.